Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Oct 21:5:23.
doi: 10.1186/1471-2296-5-23.

Symptomatic hypogammaglobulinemia in infancy and childhood - clinical outcome and in vitro immune responses

Affiliations

Symptomatic hypogammaglobulinemia in infancy and childhood - clinical outcome and in vitro immune responses

Mona Iancovici Kidon et al. BMC Fam Pract. .

Abstract

Background: Symptomatic hypogammaglobulinemia in infancy and childhood (SHIC), may be an early manifestation of a primary immunodeficiency or a maturational delay in the normal production of immunoglobulins (Ig). We aimed to evaluate the natural course of SHIC and correlate in vitro lymphoproliferative and secretory responses with recovery of immunoglobulin values and clinical resolution.

Methods: Children, older than 1 year of age, referred to our specialist clinic because of recurrent infections and serum immunoglobulin (Ig) levels 2 SD below the mean for age, were followed for a period of 8 years. Patient with any known familial, clinical or laboratory evidence of cellular immunodeficiency or other immunodeficiency syndromes were excluded from this cohort. Evaluation at 6- to 12-months intervals continued up to 1 year after resolution of symptoms. In a subgroup of patients, in vitro lymphocyte proliferation and Ig secretion in response to mitogens was performed.

Results: 32 children, 24 (75%) males, 8 (25%) females, mean age 3.4 years fulfilled the inclusion criteria.

Clinical presentation: ENT infections 69%, respiratory 81%, diarrhea 12.5%. During follow-up, 17 (53%) normalized serum Ig levels and were diagnosed as transient hypogammaglobulinemia of infancy (THGI). THGI patients did not differ clinically or demographically from non-transient patients, both having a benign clinical outcome. In vitro Ig secretory responses, were lower in hypogammaglobulinemic, compared to normal children and did not normalize concomitantly with serum Ig's in THGI patients.

Conclusions: The majority of children with SHIC in the first decade of life have THGI. Resolution of symptoms as well as normalization of Ig values may be delayed, but overall the clinical outcome is good and the clinical course benign.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Lymphocyte proliferation after in-vitro mitogenic stimuli in Pediatric Hypogammaglobulinemia. SAC – Staph. Aureus Cowan. PWM – Pokeweed Mitogen PHA – Phytohemmaglutinin LPS – Lipopolysacharide Values are given as Stimulation Index (SI) mean ± 95% CI, ** p < 0.005

Similar articles

Cited by

References

    1. Rosen FS, Wedgwood RJP, Eibl M, Fischer A, Aiuti F, Notarangelo L, Kishimoto T, Resnick IB, Hammarstrom L, Seger R, Chapel H. Report of a WHO Scientific Group: Primary Immunodeficiency Diseases. Clin Exp Immunol. 1997;109:1–28. - PubMed
    1. Golan H, Dalal I, Garty BZ, Schlesinger M, Levy J, Handzel Z, Wolach B, Rottem M, Goldberg A, Tamir R, Koren A, Levy Y, Katz Y, Passwell J, Etzioni A. The incidence of primary immunodeficiency syndromes in Israel. Isr Med Assoc J. 2002;4:868–71. - PubMed
    1. Primary Immunodeficiency Diseases: A molecular and genetic approach. New York: Oxford University Press; 1999.
    1. Fischer A. Primary immunodeficiency diseases: natural mutant models for the study of the immune system. Scand J Immunol. 2002;55:238–41. doi: 10.1046/j.1365-3083.2002.01056.x. - DOI - PubMed
    1. Kowalczyk D, Baran J, Webster AD, Zembala M. Intracellular cytokine production by Th1/Th2 lymphocytes and monocytes of children with symptomatic transient hypogammaglobulinaemia of infancy (THI) and selective IgA deficiency (SIgAD) Clin Exp Immunol. 2002;127:507–12. doi: 10.1046/j.1365-2249.2002.01701.x. - DOI - PMC - PubMed

MeSH terms